GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction

Objectives At the present time, there is no criterion to estimate the optimal treatment for heart failure (HF) with preserved ejection fraction (HFpEF). In the past, our group suggested the criteria for diagnosis of HFpEF with normal EF and fluid overload using the size of the femoral vein (FV), mea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-10, Vol.70 (16), p.C146-C147
Hauptverfasser: Nguyen, Thach, Duong, Khanh, Tuyet Nhi, Luong Ngoc, Tri Nhan, Nguyen Minh, Phuoc, Luong Thanh, Rigatelli, Gianluca
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page C147
container_issue 16
container_start_page C146
container_title Journal of the American College of Cardiology
container_volume 70
creator Nguyen, Thach
Duong, Khanh
Tuyet Nhi, Luong Ngoc
Tri Nhan, Nguyen Minh
Phuoc, Luong Thanh
Rigatelli, Gianluca
description Objectives At the present time, there is no criterion to estimate the optimal treatment for heart failure (HF) with preserved ejection fraction (HFpEF). In the past, our group suggested the criteria for diagnosis of HFpEF with normal EF and fluid overload using the size of the femoral vein (FV), measured by ultrasound.
doi_str_mv 10.1016/j.jacc.2017.07.530
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1951658530</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717385388</els_id><sourcerecordid>1951658530</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1240-4cbee8df20a3163dc58c29a3e35c720745a157d5c744f77a6861a162786c34583</originalsourceid><addsrcrecordid>eNp9kNtO4zAQhi20SHSBF-DK0l4n2HF8iMQNKhSQOEmAuLSMMwFnW6c7dot4AN6blO41V3PQ_DPzf4QccVZyxtVxX_bO-7JiXJdMl1KwHTLhUppCyEb_IhOmhSw4a_Qe-Z1SzxhThjcT8nnxXJkCmJaK3sI7dbGlZ9CFGHJYA71x-BeQTofYBVyE-ErzG9C7ZQ4LN6cP2eVVoiF-dx8RXF5AzHTo6CU4zHTmwnyFQN9DfqP3CAlwDS0978HnMEQ6Q_edHJDdzs0THP6P--Rpdv44vSyu7y6upqfXhedVzYravwCYtquYE1yJ1kvjq8YJENLriulaOi51OxZ13WntlFHccVVpo7yopRH75M927xKHfytI2fbDCuN40vJGciXNSG6cqrZTHoeUEDq7xNEvfljO7Aa37e0Gt93gtkzbrehkK4Lx_3UAtMkHiB7agKNb2w7hJ_kXudOHeA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1951658530</pqid></control><display><type>article</type><title>GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Nguyen, Thach ; Duong, Khanh ; Tuyet Nhi, Luong Ngoc ; Tri Nhan, Nguyen Minh ; Phuoc, Luong Thanh ; Rigatelli, Gianluca</creator><creatorcontrib>Nguyen, Thach ; Duong, Khanh ; Tuyet Nhi, Luong Ngoc ; Tri Nhan, Nguyen Minh ; Phuoc, Luong Thanh ; Rigatelli, Gianluca</creatorcontrib><description>Objectives At the present time, there is no criterion to estimate the optimal treatment for heart failure (HF) with preserved ejection fraction (HFpEF). In the past, our group suggested the criteria for diagnosis of HFpEF with normal EF and fluid overload using the size of the femoral vein (FV), measured by ultrasound.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.07.530</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Heart diseases ; Heart failure ; Patients ; Ultrasonic imaging ; Veins &amp; arteries</subject><ispartof>Journal of the American College of Cardiology, 2017-10, Vol.70 (16), p.C146-C147</ispartof><rights>2017</rights><rights>Copyright Elsevier Limited Oct 17, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109717385388$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Nguyen, Thach</creatorcontrib><creatorcontrib>Duong, Khanh</creatorcontrib><creatorcontrib>Tuyet Nhi, Luong Ngoc</creatorcontrib><creatorcontrib>Tri Nhan, Nguyen Minh</creatorcontrib><creatorcontrib>Phuoc, Luong Thanh</creatorcontrib><creatorcontrib>Rigatelli, Gianluca</creatorcontrib><title>GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction</title><title>Journal of the American College of Cardiology</title><description>Objectives At the present time, there is no criterion to estimate the optimal treatment for heart failure (HF) with preserved ejection fraction (HFpEF). In the past, our group suggested the criteria for diagnosis of HFpEF with normal EF and fluid overload using the size of the femoral vein (FV), measured by ultrasound.</description><subject>Cardiology</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Patients</subject><subject>Ultrasonic imaging</subject><subject>Veins &amp; arteries</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kNtO4zAQhi20SHSBF-DK0l4n2HF8iMQNKhSQOEmAuLSMMwFnW6c7dot4AN6blO41V3PQ_DPzf4QccVZyxtVxX_bO-7JiXJdMl1KwHTLhUppCyEb_IhOmhSw4a_Qe-Z1SzxhThjcT8nnxXJkCmJaK3sI7dbGlZ9CFGHJYA71x-BeQTofYBVyE-ErzG9C7ZQ4LN6cP2eVVoiF-dx8RXF5AzHTo6CU4zHTmwnyFQN9DfqP3CAlwDS0978HnMEQ6Q_edHJDdzs0THP6P--Rpdv44vSyu7y6upqfXhedVzYravwCYtquYE1yJ1kvjq8YJENLriulaOi51OxZ13WntlFHccVVpo7yopRH75M927xKHfytI2fbDCuN40vJGciXNSG6cqrZTHoeUEDq7xNEvfljO7Aa37e0Gt93gtkzbrehkK4Lx_3UAtMkHiB7agKNb2w7hJ_kXudOHeA</recordid><startdate>20171017</startdate><enddate>20171017</enddate><creator>Nguyen, Thach</creator><creator>Duong, Khanh</creator><creator>Tuyet Nhi, Luong Ngoc</creator><creator>Tri Nhan, Nguyen Minh</creator><creator>Phuoc, Luong Thanh</creator><creator>Rigatelli, Gianluca</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20171017</creationdate><title>GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction</title><author>Nguyen, Thach ; Duong, Khanh ; Tuyet Nhi, Luong Ngoc ; Tri Nhan, Nguyen Minh ; Phuoc, Luong Thanh ; Rigatelli, Gianluca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1240-4cbee8df20a3163dc58c29a3e35c720745a157d5c744f77a6861a162786c34583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cardiology</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Patients</topic><topic>Ultrasonic imaging</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Thach</creatorcontrib><creatorcontrib>Duong, Khanh</creatorcontrib><creatorcontrib>Tuyet Nhi, Luong Ngoc</creatorcontrib><creatorcontrib>Tri Nhan, Nguyen Minh</creatorcontrib><creatorcontrib>Phuoc, Luong Thanh</creatorcontrib><creatorcontrib>Rigatelli, Gianluca</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Thach</au><au>Duong, Khanh</au><au>Tuyet Nhi, Luong Ngoc</au><au>Tri Nhan, Nguyen Minh</au><au>Phuoc, Luong Thanh</au><au>Rigatelli, Gianluca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2017-10-17</date><risdate>2017</risdate><volume>70</volume><issue>16</issue><spage>C146</spage><epage>C147</epage><pages>C146-C147</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Objectives At the present time, there is no criterion to estimate the optimal treatment for heart failure (HF) with preserved ejection fraction (HFpEF). In the past, our group suggested the criteria for diagnosis of HFpEF with normal EF and fluid overload using the size of the femoral vein (FV), measured by ultrasound.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2017.07.530</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2017-10, Vol.70 (16), p.C146-C147
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1951658530
source Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Cardiology
Heart diseases
Heart failure
Patients
Ultrasonic imaging
Veins & arteries
title GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A23%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GW28-e0756%20New%20and%20Definitive%20Marker%20Confirming%20the%20Optimal%20Status%20in%20the%20Treatment%20of%20Heart%20Failure%20with%20Preserved%20Ejection%20Fraction&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Nguyen,%20Thach&rft.date=2017-10-17&rft.volume=70&rft.issue=16&rft.spage=C146&rft.epage=C147&rft.pages=C146-C147&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.07.530&rft_dat=%3Cproquest_cross%3E1951658530%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1951658530&rft_id=info:pmid/&rft_els_id=S0735109717385388&rfr_iscdi=true